疲劳 发表于 2025-3-23 11:36:27

http://reply.papertrans.cn/3/291/29019/29019-11.png

热心 发表于 2025-3-23 17:55:15

Submitted on: 30 December 2001.
Revised on: 11 February 2002.
Accepted on: 06 March 2002.
SURGICAL ONCOLOGY-OXFORD---ELSEVIER SCI LTD

crease 发表于 2025-3-23 19:54:47

http://reply.papertrans.cn/3/291/29019/29019-13.png

收藏品 发表于 2025-3-23 23:37:32

Submitted on: 05 July 2006.
Revised on: 03 August 2006.
Accepted on: 20 August 2006.
SURGICAL ONCOLOGY-OXFORD

全等 发表于 2025-3-24 06:16:44

Submitted on: 19 June 2000.
Revised on: 10 July 2000.
Accepted on: 17 July 2000.
SURGICAL ONCOLOGY-OXFORD---ELSEVIER SCI LTD

庇护 发表于 2025-3-24 09:20:50

http://reply.papertrans.cn/3/291/29019/29019-16.png

不出名 发表于 2025-3-24 10:54:18

http://reply.papertrans.cn/3/291/29019/29019-17.png

Abominate 发表于 2025-3-24 17:35:17

Submitted on: 12 October 2015.
Revised on: 05 November 2015.
Accepted on: 01 December 2015.
SURGICAL ONCOLOGY-OXFORD---ELSEVIER SCI LTD

种族被根除 发表于 2025-3-24 19:52:43

http://reply.papertrans.cn/3/291/29019/29019-19.png

执拗 发表于 2025-3-25 01:47:42

http://reply.papertrans.cn/3/291/29019/29019-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊SURGICAL ONCOLOGY-OXFORD 2024/2025影响因子:2.388 (SURG ONCOL) (0960-7404). (ONCOLOGY)(肿瘤学)Science Citation Index Expa